  This is a case report of a 40-year-old woman who , after conservative breast cancer treatment , developed a HER2 positive solitary brain metastasis in the left temporal lobe , without extracranial disease. She underwent surgery resection followed by stereotactic radiotherapy and , because of early brain progression , she was submitted to the first line therapy with pertuzumab , trastuzumab and weekly paclitaxel. After six months of treatment , a brain magnetic resonance imaging revealed a complete disappearance of brain recurrence , which persisted for more than 24 months.